Victrex plc Stock

Equities

VCT

GB0009292243

Specialty Chemicals

Market Closed - London S.E. 11:35:24 2024-04-16 am EDT 5-day change 1st Jan Change
1,244 GBX -2.96% Intraday chart for Victrex plc -3.57% -18.27%
Sales 2024 * 307M 383M Sales 2025 * 329M 409M Capitalization 1.11B 1.39B
Net income 2024 * 61M 75.93M Net income 2025 * 73M 90.87M EV / Sales 2024 * 3.55 x
Net cash position 2024 * 23.88M 29.72M Net cash position 2025 * 43.63M 54.31M EV / Sales 2025 * 3.26 x
P/E ratio 2024 *
18.2 x
P/E ratio 2025 *
15.4 x
Employees 1,109
Yield 2024 *
4.62%
Yield 2025 *
5.11%
Free-Float 98.38%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.62%
1 week-1.84%
Current month-1.31%
1 month+2.40%
3 months-9.01%
6 months-8.17%
Current year-15.77%
More quotes
1 week
1 272.00
Extreme 1272
1 352.00
1 month
1 222.00
Extreme 1222
1 352.00
Current year
1 152.00
Extreme 1152
1 545.00
1 year
1 152.00
Extreme 1152
1 716.00
3 years
1 152.00
Extreme 1152
2 720.00
5 years
1 152.00
Extreme 1152
2 720.00
10 years
1 152.00
Extreme 1152
3 438.06
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 17-08-31
Director of Finance/CFO - -
Director of Finance/CFO - 22-07-03
Members of the board TitleAgeSince
Chief Executive Officer 60 17-08-31
Chairman 63 21-11-30
Director/Board Member 68 18-02-08
More insiders
Date Price Change Volume
24-04-16 1,244 -2.96% 65 981
24-04-15 1,282 -0.62% 63,601
24-04-12 1,290 -1.98% 119,530
24-04-11 1,316 -0.30% 145,233
24-04-10 1,320 +2.33% 268,085

Delayed Quote London S.E., April 15, 2024 at 11:35 am EDT

More quotes
Victrex plc is a United Kingdom-based holding company. The principal activity of the Company is the manufacture and sale of high-performance polymers. The Company develops solutions in polyetheretherketone (PEEK) and polyaryletherketone (PAEK) based polymers and selects semi-finished and finished parts. The Company operates through two segments: Sustainable Solutions and Medical. The Sustainable Solutions segment focuses on its energy and industrial, value-added resellers (VAR), automotive, aerospace and electronics markets. The Medical segment is focused on providing specialist solutions for medical device manufacturers. The Company’s subsidiaries include Victrex Manufacturing Limited, Invibio Limited, Invibio Knees Limited, Invibio Device Component Manufacturing Limited and Juvora Limited.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
12.82 GBP
Average target price
15.2 GBP
Spread / Average Target
+18.55%
Consensus